Shandong Boan Biotechnology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

The United Laboratories International Holdings Ltd.

Beijing Tong Ren Tang Chinese Medicine Co., Ltd.

Grand Pharmaceutical Group Ltd.

Simcere Pharmaceutical Group Ltd.

Luye Pharma Group Ltd.

SSY Group Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd.

Shandong Boan Biotechnology Co., Ltd.

InnoCare Pharma Ltd.

Keymed Biosciences, Inc.

Why is Shandong Boan Biotechnology Co., Ltd. ?

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Poor long term growth as Operating profit has grown by an annual rate 4.66% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -0.67%, its profits have risen by 87.2% ; the PEG ratio of the company is 0.4

Below par performance in long term as well as near term

Along with generating -0.67% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shandong Boan Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shandong Boan Biotechnology Co., Ltd.

-0.67%

-0.03

97.52%

Hang Seng Hong Kong

27.36%

1.06

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.07%

EBIT Growth (5y)

4.66%

EBIT to Interest (avg)

-0.23

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.34

Sales to Capital Employed (avg)

45.84

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.94

EV to EBIT

-180.21

EV to EBITDA

-184.56

EV to Capital Employed

3.93

EV to Sales

22.47

PEG Ratio

0.38

Dividend Yield

ROCE (Latest)

-2.18%

ROE (Latest)

24.31%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Shandong Boan Biotechnology Co., Ltd.

Pre-Tax Profit

At HKD 12.49 MM has Grown at 11,327.89%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Net Profit

At HKD 12.49 MM has Grown at 8,403.48%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (HKD MM)

Operating Profit

Highest at HKD 73.1 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (HKD MM)

Operating Profit Margin

Highest at 18.54 % and Grown

In each period in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Net Sales

Highest at HKD 394.19 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Raw Material Cost

Fallen by -24.55% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

At HKD 48.38 MM has Grown at 57.68%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Shandong Boan Biotechnology Co., Ltd.

Inventory Turnover Ratio

Lowest at 1.1% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Interest

Highest at HKD 21.76 MM

in the last five periods and Increased by 59.39% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Debtors Turnover Ratio

Lowest at 1.81%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio